AVMV targets the sweet spot of mid-cap value investing where companies are large enough to be stable but small enough to be overlooked. It aims to capture the historically higher returns of mid-cap value stocks through a systematic approach that goes beyond simple price ratios.
How It Works
The fund uses a multi-factor approach combining traditional value metrics (price-to-book, price-to-earnings) with profitability screens to avoid value traps. Holdings are weighted by market cap but tilted toward deeper value characteristics. The strategy rebalances quarterly to maintain value exposure while controlling turnover. Unlike pure index funds, AVMV applies proprietary screens to filter out distressed companies that look cheap for good reasons.
Key Features
- Combines value metrics with quality screens to avoid classic value traps in mid-cap space
- Lower turnover than typical mid-cap value funds through patient rebalancing approach
- Targets the $2-10B market cap range where institutional neglect creates pricing inefficiencies
Risks
- Mid-cap value can underperform for years — style was down 20%+ vs growth in recent decade
- Concentrated in cyclical sectors like financials and industrials that get hammered in recessions
- New fund with no track record — Avantis methodology untested in this specific market segment
Who Should Own This
Best for patient investors who believe in mean reversion and want to diversify away from mega-cap growth dominance. Works well as a 10-20% satellite position for those overweight in S&P 500 funds. Not for anyone who'll bail after a year of underperformance — this is a 5+ year commitment to a contrarian bet.